Found: 11
Select item for more details and to access through your institution.
Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy.
- Published in:
- PLoS Biology, 2019, v. 17, n. 6, p. 1, doi. 10.1371/journal.pbio.3000286
- By:
- Publication type:
- Article
Correction: Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20).
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20).
- Published in:
- Cancer Nanotechnology (1868-6958), 2023, v. 14, n. 1, p. 1, doi. 10.1186/s12645-023-00230-6
- By:
- Publication type:
- Article
Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20).
- Published in:
- Cancer Nanotechnology (1868-6958), 2023, v. 14, n. 1, p. 1, doi. 10.1186/s12645-023-00230-6
- By:
- Publication type:
- Article
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.
- Published in:
- Journal of Nanobiotechnology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12951-022-01259-2
- By:
- Publication type:
- Article
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-020-00752-w
- By:
- Publication type:
- Article
Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45160-9
- By:
- Publication type:
- Article
A Voxel Generator Based on Autoencoder.
- Published in:
- Applied Sciences (2076-3417), 2022, v. 12, n. 21, p. 10757, doi. 10.3390/app122110757
- By:
- Publication type:
- Article
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis.
- Published in:
- Inflammation & Regeneration, 2023, v. 43, n. 1, p. 1, doi. 10.1186/s41232-023-00264-8
- By:
- Publication type:
- Article
Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94298-y
- By:
- Publication type:
- Article
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87271-2
- By:
- Publication type:
- Article